FASEB's "The Steroid Hormones and Receptors in Health and Disease Conference - Jointly hosted by FASEB and the International Committee on Rapid Responses to Steroid Hormones (RRSH)"
FASEB's "The Steroid Hormones and Receptors in Health and Disease Conference - Jointly hosted by FASEB and the International Committee on Rapid Responses to Steroid Hormones (RRSH)"
批准号:
10063235
负责人:
Daniel Edward Frigo
金额:
$1.75万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-07-21 至 2021-07-20
关键词:
AdoptedAnimal ModelAreaAutomobile DrivingBiological ModelsBiological ProcessCancer BiologyCell NucleusCell physiologyCollaborationsCommunitiesComplexConsensusCytosolDataDiseaseEndocrineEndocrine systemEndocrinologyEnsureFacultyFinancial SupportFosteringFundingGene Expression RegulationGenetic TranscriptionGenomicsHealthHumanHypothyroidismIndividualInternationalJointsKnowledgeLeadLigandsMediatingMembraneMetabolismNeuroendocrinologyNuclearOsteoporosisPaperParticipantPathologicPhysiologicalPhysiologyPostdoctoral FellowProcessProteinsPublishingReceptor SignalingResearchResearch PersonnelRoleScientistSecond Messenger SystemsSeriesServicesSignal PathwaySignal TransductionStructureSurfaceSystemTestingThinkingTimeWorkbasecareercareer developmentfaculty mentorgraduate studenthormonal signalsinnovationinsightinterestmeetingsmembernon-genomicnovelpeerpostersprofessorreceptorreceptor functionresponsesteroid hormonesteroid hormone receptorsymposiumtranscription factorunpublished works
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Historically, research in the field of steroid hormone signaling has been primarily focused on the transcriptional
effects mediated by steroid hormone receptors (SHRs) acting within the nuclei of cells. It is now recognized that
the same nuclear SHRs that trigger changes in cellular physiology through the regulation of gene expression
can be post-translationally modified and subsequently localized to the cytosol and/or surface membrane to
mobilize a variety of intracellular signaling pathways. In addition, new SHRs that function solely outside the
nucleus have been identified. These extranuclear effects of SHRs regulate a myriad of biological processes
relevant to human health and disease. SHRs rarely act in isolation, but rather synchronize cytoplasmic and
nuclear signaling pathways via complex networks of interacting molecules that serve to optimize physiological
endocrine functions. Conversely, dysfunctional endocrine systems have a profound impact on health and can
lead to various disease states. Not surprisingly, the field has rapidly expanded, such that hundreds of scientific
papers are published on the topic each year. Thus, to better understand the myriad of SHR-regulated signaling
pathways and their physiological and pathological impact, it is essential to bring together researchers across the
field of endocrinology to disseminate new findings, generate novel hypotheses, find consensus on current issues
and best approaches, and uncover new and/or unifying themes. To do so, the members of the FASEB scientific
research group “Rapid Signaling and Genomic Steroid Hormone Actions in Health & Disease" will come together
for the first time to with the participants of the international “Rapid Responses to Steroid Hormones” (RRSH) to
explore emerging data regarding the integration of nuclear and extranuclear SHR function. The title of this joint
conference is “The Rapid Signaling and Genomic Steroid Hormone Actions in Health and Disease.” The major
aims of this conference are to (1) highlight recent research discoveries in the context of integrated SHR actions
relevant to health and disease (2) promote the career development of emerging scientists and trainees to ensure
the continued vibrancy of the field and (3) further existing research interactions to foster new partnerships that
will advance knowledge and foster innovation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Revisiting Antiangiogenic Therapy to Target Hormone-Sensitive Prostate Cancer Metabolism
-
批准号:10671250
-
项目类别:
-
资助金额:$56.69万
-
财政年份:2023
-
负责人:Daniel Edward Frigo
-
依托单位:
Delineation of the Role of CAMKK2 in Bone-metastatic Prostate Cancer and its Therapeutic Implications
-
批准号:10593983
-
项目类别:
-
资助金额:$8.03万
-
财政年份:2022
-
负责人:Daniel Edward Frigo
-
依托单位:
Delineation of the Role of CAMKK2 in Bone-metastatic Prostate Cancer and its Therapeutic Implications
-
批准号:10435266
-
项目类别:
-
资助金额:$9.58万
-
财政年份:2022
-
负责人:Daniel Edward Frigo
-
依托单位:
Genetic & Metabolic Dissection of the CaMKKbeta Signaling Axis in Prostate Cancer
-
批准号:8818191
-
项目类别:
-
资助金额:$36.2万
-
财政年份:2015
-
负责人:Daniel Edward Frigo
-
依托单位:
Androgen Receptor- and Myc-Mediated Glutamine Metabolism in Prostate Cancer
-
批准号:8809478
-
项目类别:
-
资助金额:$20.25万
-
财政年份:2015
-
负责人:Daniel Edward Frigo
-
依托单位:
Genetic & Metabolic Dissection of the CaMKKbeta Signaling Axis in Prostate Cancer
-
批准号:9179334
-
项目类别:
-
资助金额:$5.44万
-
财政年份:2015
-
负责人:Daniel Edward Frigo
-
依托单位:
Genetic & Metabolic Dissection of the CaMKKbeta Signaling Axis in Prostate Cancer
-
批准号:9207070
-
项目类别:
-
资助金额:$34.98万
-
财政年份:2015
-
负责人:Daniel Edward Frigo
-
依托单位:
Genetic & Metabolic Dissection of the CaMKKbeta Signaling Axis in Prostate Cancer
-
批准号:9000138
-
项目类别:
-
资助金额:$34.98万
-
财政年份:2015
-
负责人:Daniel Edward Frigo
-
依托单位:
Androgen Receptor- and Myc-Mediated Glutamine Metabolism in Prostate Cancer
-
批准号:8997483
-
项目类别:
-
资助金额:$16.98万
-
财政年份:2015
-
负责人:Daniel Edward Frigo
-
依托单位:
Modulation of Branched-Chain Fatty Acids for the Prevention of Prostate Cancer
-
批准号:8469411
-
项目类别:
-
资助金额:$7.05万
-
财政年份:2012
-
负责人:Daniel Edward Frigo
-
依托单位:
Modulation of Branched-Chain Fatty Acids for the Prevention of Prostate Cancer
-
批准号:8236244
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2012
-
负责人:Daniel Edward Frigo
-
依托单位:
Androgenic Regulation of Autophagy in the Prostate
-
批准号:8269891
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2011
-
负责人:Daniel Edward Frigo
-
依托单位:
Androgenic Regulation of Autophagy in the Prostate
-
批准号:8174574
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2011
-
负责人:Daniel Edward Frigo
-
依托单位:
Nonclassical signaling of the androgen receptor polyproline domain
-
批准号:7708419
-
项目类别:
-
资助金额:$10.55万
-
财政年份:2009
-
负责人:Daniel Edward Frigo
-
依托单位:
Nonclassical signaling of the androgen receptor polyproline domain
-
批准号:7920248
-
项目类别:
-
资助金额:$13.88万
-
财政年份:2009
-
负责人:Daniel Edward Frigo
-
依托单位:
Nonclassical signaling of the androgen receptor polyproline domain
-
批准号:8142842
-
项目类别:
-
资助金额:$13.88万
-
财政年份:2009
-
负责人:Daniel Edward Frigo
-
依托单位:
Estrogen Receptor Beta Pharmacology in the Prostate
-
批准号:7256950
-
项目类别:
-
资助金额:$5.04万
-
财政年份:2005
-
负责人:Daniel Edward Frigo
-
依托单位:
Estrogen Receptor Beta Pharmacology in the Prostate
-
批准号:7095899
-
项目类别:
-
资助金额:$4.88万
-
财政年份:2005
-
负责人:Daniel Edward Frigo
-
依托单位:
Estrogen Receptor Beta Pharmacology in the Prostate
-
批准号:6994972
-
项目类别:
-
资助金额:$4.4万
-
财政年份:2005
-
负责人:Daniel Edward Frigo
-
依托单位:
海外基金